Net Cash Provided by (Used in) Financing Activities of Ocean Biomedical, Inc. from 30 Jun 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ocean Biomedical, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2021 to 31 Mar 2025.
  • Ocean Biomedical, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $909,000.
  • Ocean Biomedical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $3,400,000, a 67% decline from 2023.
  • Ocean Biomedical, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $10,399,000, a 975% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Ocean Biomedical, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $909,000 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2023 $2,923,000 +$2,324,000 +388% 01 Jan 2023 31 Mar 2023 10-Q 23 Dec 2024 2024 Q1
Q1 2022 $599,000 01 Jan 2022 31 Mar 2022 10-Q/A 15 Apr 2024 2023 Q1
Q3 2021 $108,970,008 17 Jun 2021 30 Sep 2021 10-Q 17 Oct 2022 2022 Q3
Q2 2021 $40,210 17 Jun 2021 30 Jun 2021 10-Q 11 Jul 2022 2022 Q2

Ocean Biomedical, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,400,000 -$6,999,000 -67% 01 Jan 2024 31 Dec 2024 10-K 08 Apr 2025 2024 FY
2023 $10,399,000 +$9,432,000 +975% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2025 2024 FY
2022 $967,000 01 Jan 2022 31 Dec 2022 10-K 25 Nov 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.